Effective Treatment of SSTR2-Positive Small Cell Lung Cancer Using ²¹¹At-Containing Targeted α-Particle Therapy Agent Which Promotes Endogenous Antitumor Immune Response.

In the PBS group, the expression of MHC-I and calreticulin in tumor tissues was always decreased on day 1, 4, and 8 after the first administration. In the 1110 kBq administration group, the expression of MHC-I and calreticulin showed a trend of first increasing and then decreasing over time.

also in 53,322 other papers